Evidence indicates that IL-13 modulates glucose homeostasis via the IL-13rα1-STAT3 signaling pathway in hepatocytes, potentially providing a therapeutic target for glucose regulation in T2D (42). This evidence concerns the gene STAT3 and type 2 diabetes mellitus.